Search research articles
Contact Us
Filters
Showing results (101-110 of 1,111) with videos related to
Page
of 112
Sort By:
Emergency Radiology
|
January 15, 2011
Myocardial infarction after blunt chest trauma: usefulness of cardiac ECG-gated CT and MRI for positive and aetiologic diagnosis
Gregory Malbranque, Jean Michel Serfaty, Dominique Himbert, et al.
Lancet (London, England)
|
September 2, 2008
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Kim Fox, Ian Ford, P Gabriel Steg, et al.
Thrombosis and Haemostasis
|
April 8, 2009
Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction
Marie-Geneviève Huisse, Nadine Ajzenberg, Laurent Feldman, et al.
BMC Medical Research Methodology
|
April 3, 2016
On the use of propensity scores in case of rare exposure
David Hajage, Florence Tubach, Philippe Gabriel Steg, et al.
Wiener Klinische Wochenschrift
|
September 16, 2017
Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry
Irene M Lang, Roza Badr-Eslam, Nicola Greenlaw, et al.
European Heart Journal
|
September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox, Ian Ford, Ph Gabriel Steg, et al.
The American Journal of Medicine
|
February 19, 2018
The Reply
Paul R Kalra, Nicola Greenlaw, Ian Ford, et al.
American Heart Journal
|
June 22, 2015
Early P2Y12 inhibition in ST-segment elevation myocardial infarction: Bridging the gap
Dimitrios Alexopoulos, Deepak L Bhatt, Chistian W Hamm, et al.
The New England Journal of Medicine
|
September 2, 2014
Ivabradine in stable coronary artery disease without clinical heart failure
Kim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Journal of the American Heart Association
|
July 2, 2021
Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
Leonardo De Luca, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Page
of 112
Search research articles
Search
Showing results (101-110 of 1,111) with videos related to
Sort By:
Page
of 112
Emergency Radiology
|
January 15, 2011
Myocardial infarction after blunt chest trauma: usefulness of cardiac ECG-gated CT and MRI for positive and aetiologic diagnosis
Gregory Malbranque, Jean Michel Serfaty, Dominique Himbert, et al.
Lancet (London, England)
|
September 2, 2008
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Kim Fox, Ian Ford, P Gabriel Steg, et al.
Thrombosis and Haemostasis
|
April 8, 2009
Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction
Marie-Geneviève Huisse, Nadine Ajzenberg, Laurent Feldman, et al.
BMC Medical Research Methodology
|
April 3, 2016
On the use of propensity scores in case of rare exposure
David Hajage, Florence Tubach, Philippe Gabriel Steg, et al.
Wiener Klinische Wochenschrift
|
September 16, 2017
Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry
Irene M Lang, Roza Badr-Eslam, Nicola Greenlaw, et al.
European Heart Journal
|
September 2, 2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox, Ian Ford, Ph Gabriel Steg, et al.
The American Journal of Medicine
|
February 19, 2018
The Reply
Paul R Kalra, Nicola Greenlaw, Ian Ford, et al.
American Heart Journal
|
June 22, 2015
Early P2Y12 inhibition in ST-segment elevation myocardial infarction: Bridging the gap
Dimitrios Alexopoulos, Deepak L Bhatt, Chistian W Hamm, et al.
The New England Journal of Medicine
|
September 2, 2014
Ivabradine in stable coronary artery disease without clinical heart failure
Kim Fox, Ian Ford, Philippe Gabriel Steg, et al.
Journal of the American Heart Association
|
July 2, 2021
Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
Leonardo De Luca, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Page
of 112